Role of angiotensin converting enzyme and angiotensinogen gene polymorphisms in angiotensin converting enzyme inhibitor-mediated antiproteinuric action in type 2 diabetic nephropathy patients

doi:10.4239/wjd.v8.i3.112

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 8, Issue 3

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (9758)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Tables (1-6) series.

Item

Count

PDF

512

WORD

404

HTML

3662

Tables (1-6)

168

Sum=4746

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

780

Download

1804

Sum=2584

Publishing Process of This Article

Item

Count

Browse

926

Download

1499

Sum=2425

Mar 15, 2017 (publication date) through May 9, 2024

Times Cited of This Article

Times Cited (7)

Journal Information of This Article

Publication Name

World Journal of Diabetes

ISSN

1948-9358

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Prospective Study

World J Diabetes. Mar 15, 2017; 8(3): 112-119
Published online Mar 15, 2017. doi: 10.4239/wjd.v8.i3.112

Table 1 Demographic and clinical characteristics of patients

Parameter	Type 2 diabetes mellitus with nephropathy
Number of patients (n)	270
Gender (male/female)	128/142
Age (yr)	52.23 ± 6.01¹
Duration of diabetes (yr)	8.31 ± 3.09¹
Family history of diabetes (yes/no)	105/165
Family history of hypertension (yes/no)	63/207
Medications
Insulin (yes/no)	115/155
Metformin (yes/no)	153/117
Glimiperide (yes/no)	129/141

¹Data are presented as mean ± SD.

Citation: Aggarwal N, Kare PK, Varshney P, Kalra OP, Madhu SV, Banerjee BD, Yadav A, Raizada A, Tripathi AK. Role of angiotensin converting enzyme and angiotensinogen gene polymorphisms in angiotensin converting enzyme inhibitor-mediated antiproteinuric action in type 2 diabetic nephropathy patients. World J Diabetes 2017; 8(3): 112-119
URL: https://www.wjgnet.com/1948-9358/full/v8/i3/112.htm
DOI: https://dx.doi.org/10.4239/wjd.v8.i3.112